S&P Global Ratings reports that India, South Korea, and Thailand are most at risk of facing higher US tariffs under the Trump ...

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...

The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...